Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 25.10
+0.30 (1.21%)
Mar 24, 2026, 1:50 PM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 4.96 billion as of March 24, 2026. Its market cap has increased by 24.34% in one year.
Market Cap
4.96B
Enterprise Value
4.21B
Revenue
5.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.10
Market Cap Chart
Since April 28, 2022, Locus Cell's market cap has decreased from 9.88B to 4.96B, a decrease of -49.79%. That is a compound annual growth rate of -16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 5.02B | -12.70% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 6.01B |
| AnnJi Pharmaceutical | 5.92B |
| Sinphar Pharmaceutical | 5.90B |
| Steminent Biotherapeutics | 5.79B |
| Panion & Bf Biotech | 5.32B |
| Senhwa Biosciences | 5.10B |
| Pharmosa Biopharm | 5.05B |
| OBI Pharma | 5.01B |